Kitazato is globally recognised as one of the pioneering brands in driving and improving vitrification. Its greatest contribution in this field has been the development of the renowned Cryotop® Method, the global leader in vitrification of oocytes and embryos, in all stages of development.
After over a decade on the market, the Cryotop® Method has been applied in over 1,500,000 clinical cases in over 90 countries and 2,200 assisted reproduction centres. Hundreds of scientific publications certify their excellent results.
The original device, globally renowned for its unparalleled Cooling and Warming Rates and its very high survival rates.
The same results and the same protocol with a new sealing for achieving vitrification without direct contact of the specimen with the liquid nitrogen.
Kitazato also has ovarian tissue vitrification devices. Cancer patients who require chemotherapy and radiotherapy treatments, and patients with premature menopause can now preserve their fertility with guarantees.